Grace Therapeutics, Inc. ($GRCE)
Filing Information
| Accession Number | 0001493152-26-045358 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 1, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
7,849
Total Value
$16,404.41
P&L
-9.6% ($1,569.80)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock, par value $0.0001 per share | โ | Sep 29, 2026 | Purchase | 7,849 | $2.09 | $16,404.41 | 2,798,167 | Indirect | By Opaleye, L.P. | View Details |